CEO exercised or converted 46K BSX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 2, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 3, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001225208-26-001156
Filed / recordedFeb 3, 2026, 9:12 PM UTCAdded to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerBOSTON SCIENTIFIC CORP Reporting personMichael F Mahoney RelationshipDirector, Officer Officer titleChairman, President & CEO TableNon-derivative (Table I) Transaction dateFeb 2, 2026 Acquired / disposedAcquired (A) Shares owned after1,572,636 Footnotes from the filing
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.